Xanthopsia in Jaundice

What is Xanthopsia in jaundice?

Xanthopsia is a visual disturbance in which objects appear yellow‑tinted or “golden.” When it occurs in the setting of jaundice—a condition marked by elevated bilirubin levels and yellowing of the skin and eyes—it reflects the impact of excess bilirubin on the retina and visual pathways. The term comes from the Greek xanthos (yellow) and opsis (vision).

In most people, the change is subtle: a white page may look creamy, a blue sky may have a faint amber hue, and colors may seem washed out. Because the symptom is rare and often nonspecific, it can be missed unless clinicians ask about changes in color perception.

Common Causes

Several medical conditions that raise bilirubin levels or directly affect the retina can produce xanthopsia in the context of jaundice. The most frequent causes include:

• Hemolytic anemia – rapid breakdown of red blood cells raises unconjugated bilirubin.
• Acute viral hepatitis (A, B, C, D, E) – liver inflammation impairs bilirubin conjugation.
• Obstructive (cholestatic) jaundice – gallstones, pancreatic cancer, or strictures block bile flow.
• Gilbert’s syndrome – a benign genetic defect in bilirubin‑UGT1A1 enzyme.
• Crigler‑Najjar syndrome (type I & II) – rare inherited disorder with severe hyperbilirubinemia.
• Drug‑induced liver injury – acetaminophen overdose, certain antibiotics, and antitubercular drugs.
• Sepsis or severe infection – systemic inflammation can precipitate cholestasis.
• Pancreatic or biliary tract tumors – compress bile ducts, causing back‑up of bilirubin.
• Autoimmune hepatitis – immune‑mediated liver damage leading to jaundice.
• Pre‑eclampsia / HELLP syndrome – maternal liver dysfunction during pregnancy.

Associated Symptoms

Because xanthopsia is a manifestation of bilirubin excess, it commonly appears alongside other signs of jaundice and liver dysfunction. Typical associated findings include:

• Yellow discoloration of the sclerae (the whites of the eyes) and skin.
• Dark urine and pale, clay‑colored stools.
• Pruritus (itching), especially on the palms and soles.
• Abdominal pain or fullness in the right upper quadrant.
• Fatigue, weakness, and loss of appetite.
• Unexplained weight loss.
• Fever or chills if an infectious cause is present.
• Confusion, asterixis, or altered mental status in severe hyperbilirubinemia (hepatic encephalopathy).

When to See a Doctor

Any new change in color perception should prompt a medical evaluation, but the urgency rises when it is paired with the following:

• Rapid darkening of urine or lightening of stools.
• Severe abdominal pain, especially if sudden or radiating to the back.
• Persistent fever >100.4 °F (38 °C) or chills.
• Sudden worsening of jaundice or spreading to the chest and hands.
• Confusion, drowsiness, or difficulty concentrating.
• Any eye pain, vision loss, or double vision.
• Signs of bleeding (easy bruising, nosebleeds, blood in stool or urine).

Prompt assessment can identify life‑threatening conditions such as acute liver failure, biliary obstruction, or severe hemolysis.

Diagnosis

Diagnosing xanthopsia itself is clinical—patients report a yellow tint, and the clinician confirms jaundice. The work‑up then focuses on identifying the underlying cause of hyperbilirubinemia.

1. History & Physical Examination

• Detailed medication and supplement inventory.
• Recent travel, sick contacts, or exposure to hepatitis risk factors.
• Family history of hereditary liver disorders.
• Physical exam for liver size, tenderness, ascites, and signs of chronic liver disease.

2. Laboratory Tests

• Serum bilirubin (total and direct) – determines whether unconjugated or conjugated bilirubin predominates.
• Alanine aminotransferase (ALT) & Aspartate aminotransferase (AST) – gauge hepatocellular injury.
• Alkaline phosphatase (ALP) & Gamma‑glutamyl transferase (GGT) – assess cholestasis.
• Complete blood count (CBC) – look for anemia or infection.
• Coagulation profile (PT/INR) – liver synthetic function.
• Serologies for hepatitis A‑E, HIV, and autoimmune markers (ANA, SMA).
• Hemolysis panel (LDH, haptoglobin, reticulocyte count) when a hemolytic cause is suspected.

3. Imaging Studies

• Ultrasound – first‑line to detect gallstones, biliary duct dilation, or liver masses.
• CT or MRI – detailed evaluation of pancreatic or hepatic tumors.
• MRCP (Magnetic Resonance Cholangiopancreatography) – non‑invasive view of the biliary tree.

4. Specialized Tests

• Endoscopic Retrograde Cholangiopancreatography (ERCP) – diagnostic and therapeutic for biliary obstruction.
• Liver biopsy – reserved for unclear cases or suspected autoimmune hepatitis.
• Genetic testing for UGT1A1 mutations when Gilbert’s or Crigler‑Najjar syndrome is suspected.

Treatment Options

Treatment is directed at the underlying cause of jaundice; the visual disturbance usually resolves once bilirubin levels normalize.

1. General Measures

• Hydration – oral or IV fluids help improve renal clearance of bilirubin.
• Phototherapy – mainly for newborns but occasionally used in adult severe hyperbilirubinemia to convert bilirubin into water‑soluble isomers.
• Discontinuation of offending drugs (e.g., acetaminophen, certain antibiotics).
• Dietary adjustments – low‑fat diet and adequate protein to support liver regeneration.

**Specific therapies based on cause**

• Hemolytic anemia: corticosteroids (immune‑mediated), splenectomy, or exchange transfusion.
• Viral hepatitis: antiviral agents (e.g., sofosbuvir/velpatasvir for HCV, entecavir or tenofovir for HBV), supportive care.
• Biliary obstruction: ERCP with stent placement, laparoscopic cholecystectomy, or tumor resection.
• Autoimmune hepatitis: prednisone ± azathioprine.
• Genetic disorders (Gilbert’s/Crigler‑Najjar): usually no treatment needed; in severe Crigler‑Najjar, liver transplantation may be curative.
• Drug‑induced liver injury: immediate cessation of the culprit drug; N‑acetylcysteine for acetaminophen toxicity.
• Sepsis‑related cholestasis: broad‑spectrum antibiotics and source control.

2. Symptom‑Focused Support

• Itch relief – cholestyramine, rifampin, or antihistamines.
• Vitamin K supplementation – if coagulopathy is present.
• Monitoring for hepatic encephalopathy – lactulose and rifaximin if needed.

Prevention Tips

While not all cases of xanthopsia are preventable, many strategies reduce the risk of severe jaundice:

• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to limit hepatitis C transmission.
• Limit alcohol intake; follow guidelines (< 14 drinks/week for men, < 7 for women).
• Maintain a healthy weight to prevent non‑alcoholic fatty liver disease (NAFLD).
• Use medications only as prescribed; avoid over‑the‑counter acetaminophen >4 g/day.
• Seek prompt medical care for persistent abdominal pain, fever, or unexplained fatigue.
• For patients with known hereditary bilirubin disorders, adhere to regular follow‑up and avoid triggers (fasting, certain drugs).
• Stay hydrated, especially during illness, to aid bilirubin excretion.

Emergency Warning Signs

---

Sources: Mayo Clinic, CDC, National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK), World Health Organization, Cleveland Clinic, Hepatology journals (Journal of Hepatology, Hepatology).